Target intelligence / Profile preview

TTC9 divergent transcript (TTC9-DT)

Target
TTC9-DT
Molecular classification
Long noncoding RNA (lncRNA), Noncoding RNA
01

Overview

TTC9-DT (TTC9 Divergent Transcript) is an RNA gene in the human genome belonging to the lncRNA class, encoded on chromosome 14 (hg38 coordinates: chr14:70,608,798-70,641,298)[5][7]. It is predicted to be involved in SRP-dependent cotranslational protein targeting to the membrane and in signal sequence recognition, likely as part of the signal recognition particle (SRP) involved in endoplasmic reticulum targeting[5][7]. TTC9-DT does not encode a protein and currently is not linked to any well-characterized biological or disease roles; therapeutic relevance has not been documented. Its molecular function, disease associations, and potential utility as a biomarker or drug target are largely uncharacterized and may warrant further study[1][5][7].

Other names
CTD-2540L5.6TTC9-DT
02

Mechanism of action

Not applicable; no drugs known to interact with or modulate TTC9-DT

03

Biological functions

Predicted involvement in SRP-dependent cotranslational protein targeting to membraneSignal sequence recognitionPossibly involved as a component in signal recognition particle, endoplasmic reticulum targeting
04

Disease associations

None established; strong evidence linking this lncRNA to disease is lacking as of current data
05

Safety considerations

None reported in current literature or gene databases
06

Interacting drugs

None reported or characterized
07

Biomarkers

None established

Beyond the preview

Go deeper on TTC9 divergent transcript (TTC9-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TTC9 divergent transcript (TTC9-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call